NCT00158730View on ClinicalTrials.gov

Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment

PHASE3CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

January 31, 2005

Conditions
Invasive AspergillosisOther Fungal Infections
Interventions
DRUG

AmBisome

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY